These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 20824884)

  • 1. Ethical considerations in industry-sponsored multiregional clinical trials.
    Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
    Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethics and stem cell therapeutics for cardiovascular disease.
    Sugarman J
    Prog Cardiovasc Dis; 2007; 50(1):1-6. PubMed ID: 17631433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM; Sugarman J; Kass N
    IRB; 1998; 20(1):1-5. PubMed ID: 11655324
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

  • 8. Module five: implementation of ethics review.
    Dhai A
    Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After Helsinki: unresolved issues in international research.
    Macklin R
    Kennedy Inst Ethics J; 2001 Mar; 11(1):17-36. PubMed ID: 12166444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical issues in the design and conduct of clinical trials in developing countries.
    Shapiro HT; Meslin EM
    N Engl J Med; 2001 Jul; 345(2):139-42. PubMed ID: 11450665
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globalization of cardiovascular clinical research: the balance between meeting medical needs and maintaining scientific standards.
    Stough WG; Zannad F; Pitt B; Goldstein S
    Am Heart J; 2007 Aug; 154(2):232-8. PubMed ID: 17643571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Justice challenges of pharmaceutical industry global research].
    Páez Moreno R
    Cuad Bioet; 2010; 21(73):375-90. PubMed ID: 21090847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
    Farrell K
    J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
    [No Abstract]   [Full Text] [Related]  

  • 18. Research ethics committees--the future.
    Harris J
    Not Polit; 2002; 18(67):123-38. PubMed ID: 15282930
    [No Abstract]   [Full Text] [Related]  

  • 19. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.